Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Atrophin 1 (ATN1) Peptide

ATN1 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN973592
  • Target See all Atrophin 1 (ATN1) products
    Atrophin 1 (ATN1)
    Origin
    Human
    Source
    • 2
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Characteristics
    This is a synthetic peptide designed for use in combination with anti-ATN1 antibody (Catalog #: ARP38087_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Purification
    Purified
  • Application Notes
    Each Investigator should determine their own optimal working dilution for specific applications.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Concentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Handling Advice
    Avoid repeated freeze-thaw cycles.
    Storage
    -20 °C
    Storage Comment
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    Atrophin 1 (ATN1)
    Synonyms
    B37 Peptide, D12S755E Peptide, DRPLA Peptide, HRS Peptide, NOD Peptide, Atr1 Peptide, Drpla Peptide, atrophin-1 Peptide, RERE Peptide, ATN1 Peptide, atrophin 1 Peptide, ATN1 Peptide, Atn1 Peptide
    Background
    Dentatorubral pallidoluysian atrophy is a rare neurodegenerative disorder characterized by cerebellar ataxia, myoclonic epilepsy, choreoathetosis, and dementia. The disorder is related to the expansion of a trinucleotide repeat within ATN1. The protein includes a serine repeat and a region of alternating acidic and basic amino acids, as well as the variable glutamine repeat. Alternative splicing results in two transcripts variants that encode the same protein.Dentatorubral pallidoluysian atrophy is a rare neurodegenerative disorder characterized by cerebellar ataxia, myoclonic epilepsy, choreoathetosis, and dementia. The disorder is related to the expansion of a trinucleotide repeat within this gene. The encoded protein includes a serine repeat and a region of alternating acidic and basic amino acids, as well as the variable glutamine repeat. Alternative splicing results in two transcripts variants that encode the same protein.

    Alias Symbols: B37, D12S755E, DRPLA, NOD, HRS

    Protein Interaction Partner: ITCH,MAGI1,MAGI2,WWP1,WWP2,CASP1,CASP3,CASP7,CASP8,A2BP1,AES,AGRN,ARF3,ATN1,ATRX,BAIAP2,BAT2,BAT2L1,BAT3,CACNB1,CASP1,CASP3,CBFA2T2,CENPJ,CHRD,CRIP2,DMPK,DVL2,ECM1,EFCAB4B,EFEMP1,EFEMP2,EWSR1,FBLN1,FBLN2,FBLN5,GAPDH,GCC1,GIGYF1,GRN,HSPG2,ITCH,JAG2,KIAA0913,KRT31,KRTAP4-12,LENG8,LRP2,LTBP1,LTBP4,LYST,MAGI1,MAGI2,MAP7D1,MBP,MDFI,MEGF11,MEGF6,MEGF8,MYST2,MYST3,MYST4,NCK2,NELL1,NELL2,NOC2L,PCSK5,PDCD6IP,PFKL,PLSCR1,PSMA3,PSME3,RAD54L2,RBM10,RBM9,RBPMS,RCHY1,RERE,RHOXF2,RNF31,RUNX1T1,SIAH1,SIAH2,SLIT1,SPAG5,SSPO,STXBP4,SYVN1,TEP1,TLE1,TRIP6,USP54,VIM,WDR5,WWP1,WWP2,ZMYND8,BAIAP2,CTNND2,DVL1,ITCH,LYST,MAGI1,MAGI2,MYST2,RERE,TLE1,VIM,WWP1,WWP2

    Protein Size: 1190
    Molecular Weight
    125 kDa
    Gene ID
    1822
    NCBI Accession
    NM_001940, NP_001931
    UniProt
    P54259
You are here:
Support